PSMD9 Antikörper
Kurzübersicht für PSMD9 Antikörper (ABIN111067)
Target
Alle PSMD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Recognizes the 20S subcomplex within the 26S hetero-oligomeric protein complex and the free cytosolic form of 20S cylinder particles, the epitope is resistant to formaldehyde fixation (up to 4 %) Antigen Recognized in Species and Cultured Cell Lines (tested so far): Xenopus laevis, XLKE-A6 (Xenopus laevis), PLC (human), RVF (rat), Ptk2 (rat, kangaroo)
-
Aufreinigung
- Hybridoma culture supernatant
-
Immunogen
- Nuclear 26S complexes of Xenopus laevis oocytes
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Immunofluorescence microscopy: Ready to use, 20 - 30 min at RT, longer incubation mayresult in loss of soluble antigen. Western Blot: 1: 100 when using the ECL method. Immunoprecipitation (Ascites*). Affinity chromatography (Ascites*).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C.
-
-
- PSMD9 (Proteasome (Prosome, Macropain) 26S Subunit, Non-ATPase, 9 (PSMD9))
-
Andere Bezeichnung
- PSMD9
-
Hintergrund
- Synonyms: 26S proteasome non-ATPase regulatory subunit 9, 26S proteasome regulatory subunit p27
-
Gen-ID
- 5715
-
NCBI Accession
- NP_002804
-
UniProt
- O00233
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Mitotic G1-G1/S Phases, DNA Replication, Synthesis of DNA, Ubiquitin Proteasome Pathway
Target
-